|
METTL10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.82789999994648E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.394340E-02 |
| Normal-vs-Stage2 |
5.937600E-02 |
| Normal-vs-Stage3 |
5.30730004388857E-09 |
| Normal-vs-Stage4 |
1.59690000001156E-07 |
| Stage1-vs-Stage2 |
5.715200E-01 |
| Stage1-vs-Stage3 |
1.59326999999987E-05 |
| Stage1-vs-Stage4 |
4.649500E-04 |
| Stage2-vs-Stage3 |
3.096500E-02 |
| Stage2-vs-Stage4 |
9.363800E-02 |
| Stage3-vs-Stage4 |
6.672600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97260000001087E-06 |
| Normal-vs-AfricanAmerican |
5.916100E-02 |
| Normal-vs-Asian |
5.816200E-02 |
| Caucasian-vs-AfricanAmerican |
2.102400E-01 |
| Caucasian-vs-Asian |
9.057600E-01 |
| AfricanAmerican-vs-Asian |
5.024200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.65890000034675E-07 |
| Normal-vs-Female |
1.662970E-03 |
| Male-vs-Female |
1.315020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.166100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.957900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.41680000001576E-06 |
| Normal-vs-Age(81-100Yrs) |
1.581020E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.106200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.641000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.251400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.731000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.812200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.498200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.639700E-02 |
| Normal-vs-Grade 2 |
5.112500E-02 |
| Normal-vs-Grade 3 |
1.50479999572184E-08 |
| Normal-vs-Grade 4 |
7.64729946034493E-10 |
| Grade 1-vs-Grade 2 |
6.077600E-03 |
| Grade 1-vs-Grade 3 |
3.90459999999315E-06 |
| Grade 1-vs-Grade 4 |
3.46200000000962E-06 |
| Grade 2-vs-Grade 3 |
1.555800E-04 |
| Grade 2-vs-Grade 4 |
1.15970000003074E-06 |
| Grade 3-vs-Grade 4 |
1.805900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.365800E-01 |
| Normal-vs-ccB subtype |
9.43829459032486E-11 |
| ccA subtype-vs-ccB subtype |
5.74589997803798E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.94709999999221E-05 |
| Normal-vs-N1 |
1.8882799999953E-05 |
| N0-vs-N1 |
3.185700E-02 |
|
|
